These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

312 related articles for article (PubMed ID: 1577872)

  • 21. Expression of dystrophin-associated proteins in dystrophin-positive muscle fibers (revertants) in Duchenne muscular dystrophy.
    Matsumura K; Tomé FM; Collin H; Leturcq F; Jeanpierre M; Kaplan JC; Fardeau M; Campbell KP
    Neuromuscul Disord; 1994 Mar; 4(2):115-20. PubMed ID: 7516752
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Plectin tethers desmin intermediate filaments onto subsarcolemmal dense plaques containing dystrophin and vinculin.
    Hijikata T; Murakami T; Ishikawa H; Yorifuji H
    Histochem Cell Biol; 2003 Feb; 119(2):109-23. PubMed ID: 12610730
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dystrophin-associated glycoprotein and dystrophin co-localisation at sarcolemma in Fukuyama congenital muscular dystrophy.
    Arahata K; Hayashi YK; Mizuno Y; Yoshida M; Ozawa M
    Lancet; 1993 Sep; 342(8871):623-4. PubMed ID: 8102757
    [No Abstract]   [Full Text] [Related]  

  • 24. Dystrophin is not essential for the integrity of the cytoskeleton.
    Massa R; Castellani L; Silvestri G; Sancesario G; Bernardi G
    Acta Neuropathol; 1994; 87(4):377-84. PubMed ID: 8017173
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dystrophin-related protein, utrophin, in normal and dystrophic human fetal skeletal muscle.
    Clerk A; Morris GE; Dubowitz V; Davies KE; Sewry CA
    Histochem J; 1993 Aug; 25(8):554-61. PubMed ID: 8407365
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dystrophin predominantly localizes to the transverse tubule/Z-line regions of single ventricular myocytes and exhibits distinct associations with the membrane.
    Peri V; Ajdukovic B; Holland P; Tuana BS
    Mol Cell Biochem; 1994 Jan; 130(1):57-65. PubMed ID: 8190121
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Complementary distributions of vinculin and dystrophin define two distinct sarcolemma domains in smooth muscle.
    North AJ; Galazkiewicz B; Byers TJ; Glenney JR; Small JV
    J Cell Biol; 1993 Mar; 120(5):1159-67. PubMed ID: 8436588
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The sarcolemma in the Large(myd) mouse.
    Reed PW; Mathews KD; Mills KA; Bloch RJ
    Muscle Nerve; 2004 Nov; 30(5):585-95. PubMed ID: 15389724
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Preferential subsarcolemmal localization of dystrophin and beta-dystroglycan mRNA in human skeletal muscles.
    Mitsui T; Kawai H; Shono M; Kawajiri M; Kunishige M; Saito S
    J Neuropathol Exp Neurol; 1997 Jan; 56(1):94-101. PubMed ID: 8990133
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dystrophin-glycoprotein complex is highly enriched in isolated skeletal muscle sarcolemma.
    Ohlendieck K; Ervasti JM; Snook JB; Campbell KP
    J Cell Biol; 1991 Jan; 112(1):135-48. PubMed ID: 1986002
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Deficiency of a glycoprotein component of the dystrophin complex in dystrophic muscle.
    Ervasti JM; Ohlendieck K; Kahl SD; Gaver MG; Campbell KP
    Nature; 1990 May; 345(6273):315-9. PubMed ID: 2188135
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dystrophin-glycoprotein complex: its role in the molecular pathogenesis of muscular dystrophies.
    Matsumura K; Campbell KP
    Muscle Nerve; 1994 Jan; 17(1):2-15. PubMed ID: 8264699
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dystrophin negative skeletal and myocardial muscle cells in a carrier of Duchenne's muscular dystrophy.
    Watanabe K; Izumi T; Natsui M; Matsubara N; Miyakita Y; Koyama S; Inomata T; Suzuki M; Shibata A
    Eur Heart J; 1993 Jul; 14(7):989-92. PubMed ID: 8375425
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Heterokaryon myotubes with normal mouse and Duchenne nuclei exhibit sarcolemmal dystrophin staining and efficient intracellular free calcium control.
    Denetclaw WF; Bi G; Pham DV; Steinhardt RA
    Mol Biol Cell; 1993 Sep; 4(9):963-72. PubMed ID: 8257798
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A dystrophin-immunoreactive protein in mammalian brain.
    Clerk A; Muntoni F; Strong PN
    J Neurochem; 1993 Feb; 60(2):435-41. PubMed ID: 8419529
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Independent variability of microtubule perturbations associated with dystrophinopathy.
    Belanto JJ; Olthoff JT; Mader TL; Chamberlain CM; Nelson DM; McCourt PM; Talsness DM; Gundersen GG; Lowe DA; Ervasti JM
    Hum Mol Genet; 2016 Nov; 25(22):4951-4961. PubMed ID: 28171583
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Loss of sarcolemma nNOS in sarcoglycan-deficient muscle.
    Crosbie RH; Barresi R; Campbell KP
    FASEB J; 2002 Nov; 16(13):1786-91. PubMed ID: 12409321
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Two populations of beta-spectrin in rat skeletal muscle.
    Porter GA; Scher MG; Resneck WG; Porter NC; Fowler VM; Bloch RJ
    Cell Motil Cytoskeleton; 1997; 37(1):7-19. PubMed ID: 9142435
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Expression of a dystrophin-related protein associated with the skeletal muscle cell membrane.
    Tanaka H; Ishiguro T; Eguchi C; Saito K; Ozawa E
    Histochemistry; 1991; 96(1):1-5. PubMed ID: 1938476
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Presence of dystrophine-like protein at the neuromuscular junction in Duchenne muscular dystrophy and in "mdx" mutant mice].
    Fardeau M; Tomé FM; Collin H; Augier N; Pons F; Léger J; Léger J
    C R Acad Sci III; 1990; 311(5):197-204. PubMed ID: 2119867
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.